Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00167310
Show Display Options
RSS Create an RSS feed from your search for:
NCT00167310
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
Conditions: Schizophrenia;   Schizoaffective Disorder;   Major Depression;   Bipolar Disorder;   Coronary Artery Disease
Interventions: Drug: Eicosapentaenoic acid (omega-3 fatty acid);   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.